The Scottish NHS has recently approved seven new drugs for use in the nation.
These include Fresenius’ Velphoro (sucroferric oxyhydroxide), which is used for ontrol phosphorus levels in adults with chronic kidney disease on haemodialysis or peritoneal dialysis, and Almirall’s chronic obstructive pulmonary disease Duaklir Genuair (Aclidinium/formoterol).
“A range of new drugs has been approved for use in Scotland.“
Also approved is Bayer's birth control intrauterine device Jaydess and Novartis’ Gilenya (fingolimod), which is intended for the treatment of patients with highly active relapsing remitting multiple sclerosis who have undergone at least one disease modifying therapy, Pharma Times reports.
Ariad Pharmaceuticals’ Iclusig (ponatinib) has been given the go ahead and will be used on Scottish patients who have Philadelphia chromosome positive acute leukaemia and chronic myeloid leukaemia.
Bayer’s Stivarga (regorafenib), a treatment for adult patients with gastrointestinal stromal tumours where surgical removal has failed or the tumors have spread, has also been approved.
The seventh drug to be passed for use in Scotland is Boehringer Ingelheim’s Vargatef (nintedanib), which is intended for people with the non-small cell lung cancer adenocarcinoma who have already had chemotherapy.See all the latest jobs in Medical Devices